Total Payments
$14,879
2024 Payments
$10,310
Companies
9
Transactions
33
Medicare Patients
1,634
Medicare Billing
$96,961
Payment Breakdown by Category
Consulting$8,300 (55.8%)
Other$3,950 (26.5%)
Travel$1,613 (10.8%)
Food & Beverage$1,017 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,300 | 5 | 55.8% |
| Honoraria | $3,950 | 2 | 26.5% |
| Travel and Lodging | $1,613 | 3 | 10.8% |
| Food and Beverage | $1,017 | 23 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $8,127 | 6 | $0 (2024) |
| Horizon Therapeutics plc | $4,265 | 11 | $0 (2023) |
| Amgen Inc. | $2,182 | 8 | $0 (2024) |
| Allergan, Inc. | $113.35 | 1 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $57.77 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $56.47 | 2 | $0 (2022) |
| Alimera Sciences, Inc. | $42.74 | 2 | $0 (2023) |
| Alcon Vision LLC | $22.79 | 1 | $0 (2019) |
| Alcon Laboratories Inc | $11.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,310 | 14 | Genentech USA, Inc. ($8,127) |
| 2023 | $4,123 | 6 | Horizon Therapeutics plc ($4,080) |
| 2022 | $193.18 | 7 | Horizon Therapeutics plc ($170.21) |
| 2021 | $146.85 | 2 | Allergan, Inc. ($113.35) |
| 2020 | $14.41 | 1 | Horizon Therapeutics plc ($14.41) |
| 2019 | $22.79 | 1 | Alcon Vision LLC ($22.79) |
| 2018 | $57.77 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($57.77) |
| 2017 | $11.52 | 1 | Alcon Laboratories Inc ($11.52) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Consulting Fee | Cash or cash equivalent | $6,200.00 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Travel and Lodging | In-kind items and services | $1,310.32 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $268.52 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Travel and Lodging | In-kind items and services | $235.65 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Travel and Lodging | In-kind items and services | $66.59 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $46.14 | General |
| Category: Immunology | ||||||
| 11/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $113.54 | General |
| Category: TEPEZZA | ||||||
| 08/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $2,250.00 | General |
| Category: TEPEZZA | ||||||
| 05/22/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/19/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $24.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/17/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: TEPEZZA | ||||||
| 03/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,700.00 | General |
| Category: TEPEZZA | ||||||
| 12/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: TEPEZZA | ||||||
| 09/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: TEPEZZA | ||||||
| 09/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: TEPEZZA | ||||||
| 07/30/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Ophthalmology | ||||||
| 06/03/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 439 | 445 | $188,992 | $32,136 |
| 2022 | 10 | 403 | 416 | $163,239 | $22,832 |
| 2021 | 8 | 299 | 312 | $131,571 | $17,560 |
| 2020 | 7 | 493 | 505 | $230,388 | $24,433 |
Total Patients
1,634
Total Services
1,678
Medicare Billing
$96,961
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 101 | 102 | $52,686 | $8,572 | 16.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 54 | 54 | $33,384 | $4,966 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 47 | $14,054 | $4,311 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $11,560 | $2,612 | 22.6% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 34 | 34 | $17,698 | $1,951 | 11.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,432 | $1,919 | 25.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 32 | 34 | $12,010 | $1,779 | 14.8% |
| 92004 | New patient complete exam of visual system | Facility | 2023 | 24 | 24 | $15,024 | $1,756 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 18 | $5,431 | $1,362 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $5,616 | $1,240 | 22.1% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 16 | 17 | $6,080 | $667.42 | 11.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 26 | 27 | $3,835 | $481.24 | 12.5% |
| 92134 | Imaging of retina | Office | 2023 | 21 | 21 | $2,893 | $434.88 | 15.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 11 | 11 | $1,289 | $83.93 | 6.5% |
| 92004 | New patient complete exam of visual system | Facility | 2022 | 42 | 42 | $25,872 | $3,040 | 11.8% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 62 | 65 | $33,345 | $2,919 | 8.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 46 | 46 | $23,598 | $2,896 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 38 | $11,286 | $2,728 | 24.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 26 | 26 | $16,016 | $2,202 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $8,019 | $2,085 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $8,298 | $1,720 | 20.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 27 | 29 | $10,208 | $1,342 | 13.1% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 33 | 36 | $12,672 | $1,306 | 10.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,432 | $864.86 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 15 | $3,015 | $741.57 | 24.6% |
About Dr. Nikisha Richards, M.D
Dr. Nikisha Richards, M.D is a Ophthalmology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1508178419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nikisha Richards, M.D has received a total of $14,879 in payments from pharmaceutical and medical device companies, with $10,310 received in 2024. These payments were reported across 33 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($8,300).
As a Medicare-enrolled provider, Richards has provided services to 1,634 Medicare beneficiaries, totaling 1,678 services with total Medicare billing of $96,961. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Richmond, VA
- Active Since 07/08/2010
- Last Updated 11/09/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1508178419
Products in Payments
- Enspryng (Biological) $8,127
- TEPEZZA (Drug) $4,265
- TEPEZZA (Biological) $2,182
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $113.35
- VYZULTA (Drug) $57.77
- Cequa (Drug) $56.47
- ILUVIEN (Drug) $42.74
- Centurion (Device) $34.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Richmond
Ethnie Jones, M.d, M.D
Ophthalmology — Payments: $2.0M
Ophthalmology $2.0M
Byron Ladd, M.d, M.D
Ophthalmology — Payments: $31,509
Ophthalmology $31,509
Jessica Randolph, Md, MD
Ophthalmology — Payments: $17,699
Ophthalmology $17,699
Dr. Prajay Dhir, Md, MD
Ophthalmology — Payments: $12,649
Ophthalmology $12,649
Tam Dang, Md, MD
Ophthalmology — Payments: $10,254
Ophthalmology $10,254
Bryan Schwent, M.d, M.D
Ophthalmology — Payments: $6,757
Ophthalmology $6,757